• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Catalyst Pharmaceuticals, Inc. (CPRX)

    -NasdaqCM
    0.79 Jun 24, 4:00PM EDT
    |Pre-Market : 0.79 0.00 (0.00%) 9:03AM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development11,801  10,118  8,097  
    Selling General and Administrative8,597  4,474  2,215  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20,398) (14,591) (10,312)
    Income from Continuing Operations
    Total Other Income/Expenses Net165  (918)(1,843)
    Earnings Before Interest And Taxes(20,233)(15,509)(12,155)
    Interest Expense -   -   -  
    Income Before Tax(20,233)(15,509)(12,155)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(20,233)(15,509)(12,155)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (20,233) (15,509) (12,155)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (20,233) (15,509) (12,155)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.